Literature DB >> 11918229

Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS).

D Felsenberg, A J Silman, M Lunt, G Armbrecht, A A Ismail, J D Finn, W C Cockerill, D Banzer, L I Benevolenskaya, A Bhalla, J Bruges Armas, J B Cannata, C Cooper, J Dequeker, R Eastell, B Felsch, W Gowin, S Havelka, K Hoszowski, I Jajic, J Janott, O Johnell, J A Kanis, G Kragl, A Lopes Vaz, R Lorenc, G Lyritis, P Masaryk, C Matthis, T Miazgowski, G Parisi, H A P Pols, G Poor, H H Raspe, D M Reid, W Reisinger, C Schedit-Nave, J J Stepan, C J Todd, K Weber, A D Woolf, O B Yershova, J Reeve, T W O'Neill.   

Abstract

Vertebral fracture is one of the major adverse clinical consequences of osteoporosis; however, there are few data concerning the incidence of vertebral fracture in population samples of men and women. The aim of this study was to determine the incidence of vertebral fracture in European men and women. A total of 14,011 men and women aged 50 years and over were recruited from population-based registers in 29 European centers and had an interviewer-administered questionnaire and lateral spinal radiographs performed. The response rate for participation in the study was approximately 50%. Repeat spinal radiographs were performed a mean of 3.8 years following the baseline film. All films were evaluated morphometrically. The definition of a morphometric fracture was a vertebra in which there was evidence of a 20% (+4 mm) or more reduction in anterior, middle, or posterior vertebral height between films--plus the additional requirement that a vertebra satisfy criteria for a prevalent deformity (using the McCloskey-Kanis method) in the follow-up film. There were 3174 men, mean age 63.1 years, and 3,614 women, mean age 62.2 years, with paired duplicate spinal radiographs (48% of those originally recruited to the baseline survey). The age standardized incidence of morphometric fracture was 10.7/1,000 person years (pyr) in women and 5.7/1,000 pyr in men. The age-standardized incidence of vertebral fracture as assessed qualitatively by the radiologist was broadly similar-12.1/1,000 pyr and 6.8/1,000 pyr, respectively. The incidence increased markedly with age in both men and women. There was some evidence of geographic variation in fracture occurrence; rates were higher in Sweden than elsewhere in Europe. This is the first large population-based study to ascertain the incidence of vertebral fracture in men and women over 50 years of age across Europe. The data confirm the frequent occurrence of the disorder in men as well as in women and the rise in incidence with age.

Entities:  

Mesh:

Year:  2002        PMID: 11918229     DOI: 10.1359/jbmr.2002.17.4.716

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  197 in total

1.  Recombinant human parathyroid hormone. Preclinical data on rat osteosarcoma were not dismissed.

Authors:  Gemma Kuijpers; Bruce Schneider; Bruce Stadel; Eric Colman
Journal:  BMJ       Date:  2002-05-18

2.  Safety of balloon kyphoplasty in the treatment of osteoporotic vertebral compression fractures in Europe: a meta-analysis of randomized controlled trials.

Authors:  Carmen Bouza; Teresa López-Cuadrado; Nuria Almendro; José María Amate
Journal:  Eur Spine J       Date:  2014-11-16       Impact factor: 3.134

3.  [Vertebroplasty in severe osteoporosis. Technique and experience with multi-segment injection].

Authors:  P F Heini; R Orler
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

4.  [Sintering prophylaxis of a vertebral body replacement: anterior cement augmentation of vertebral end plates].

Authors:  F Geiger; K Kafchitsas; M Rauschmann
Journal:  Orthopade       Date:  2010-07       Impact factor: 1.087

Review 5.  The epidemiology of osteoporosis.

Authors:  Michael A Clynes; Nicholas C Harvey; Elizabeth M Curtis; Nicholas R Fuggle; Elaine M Dennison; Cyrus Cooper
Journal:  Br Med Bull       Date:  2020-05-15       Impact factor: 4.291

6.  Radiocalcium absorption is reduced in postmenopausal women with vertebral and most types of peripheral fractures.

Authors:  B E Christopher Nordin; Peter D O'Loughlin; Allan G Need; Michael Horowitz; Howard A Morris
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

7.  The risk and burden of vertebral fractures in Sweden.

Authors:  J A Kanis; O Johnell; A Oden; F Borgstrom; N Zethraeus; C De Laet; B Jonsson
Journal:  Osteoporos Int       Date:  2003-10-31       Impact factor: 4.507

8.  Excess mortality after hospitalisation for vertebral fracture.

Authors:  John A Kanis; Anders Oden; Olof Johnell; Chris De Laet; Bengt Jonsson
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

9.  Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis.

Authors:  P J Meunier; J Y Reginster
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

10.  The hospital cost of vertebral fractures in the EU: estimates using national datasets.

Authors:  Henrik W Finnern; David P Sykes
Journal:  Osteoporos Int       Date:  2003-04-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.